Answers are grounded in this paper and cite their sources.
constitute biomarkers [1][2][3][4].Increased intestinal permeability is reversible under anti-Tumor Necrosis Factor alpha (anti-TNFα) antibodies treatment [5].In some cases, treatment of IBD could fail, so it is necessary to find predictors of non-response [6] and algorithms that could help in therapeutic optimization.
No takes yet. Share an insight, caveat, or question.
Stéphane Paul (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: